MarginsXMarginsX
Home › Markets › CNBX

CNBX Pharmaceuticals Inc. (CNBX)

CNBX is quoted over the counter, not listed on an exchange. CNBX Pharmaceuticals Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Last trade · November 12, 2026
$0.0001
No trades since Nov 12, 2026; later closes repeat the last quote
1-year return
-66.7%
Market cap
$161K
Nano cap. From the Nov 12, 2026 last trade × 1.61B shares (10-Q cover page, Jun 17, 2026)
P/E and P/S
Net loss over the period · No revenue
On trailing twelve months to May 31, 2026 (10-Q)

Closes: Yahoo Finance daily closes, last bar 2026-11-13.

Profile

FieldValue
TickerCNBX, quoted over the counter
SEC CIK0001343009
OTC Markets tierOTCID (price source, 2026-11-13)
SEC industry codePharmaceutical Preparations
Business addressBethesda, MD
Incorporated inNV

Warning signs

Cash runway
0.7 months
$9K cash at May 31, 2026
Share count, 1 year
+1635.8%
2025-07-14 to 2026-06-17 · +9327.0% over 3 years
Going-concern doubt
Yes
10-Q filed June 24, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These conditions raise substantial doubt about the ability of the Company to continue as a going concern."
10-Q 2026-06-24
Cash and burn$9K cash; operating cash flow -$39K a quarter.Report 2026-05-31
Shares outstanding1,605,768,095 (2026-06-17); 92,511,352 a year earlier; 17,033,732 three years earlier.Cover page 2026-06-17
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorElkana Amitai CPA, Mizpeh Netofa, Israel; changed auditors 1 time in 24 months8-K 4.01 2026-10-01
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-05-31
$0-$154K-$48K$9K$1.2M$010-Q 2026-06-24
Q2 2026
2026-02-28
$0-$44K-$31K$12K$1.2M$010-Q 2026-04-14
Q1 2026
2025-11-30
$0-$114K-$47K$8K$1.2M$010-Q 2026-01-14
Q4 2025
2025-08-31
$0-$150K-$29K$15K$1.2M$010-K 2025-12-01
Q3 2025
2025-05-31
$0-$60K-$52K$14K$1.3M$010-Q 2026-06-24
Q2 2025
2025-02-28
$0-$70K-$52K$46K$1.4M$010-Q 2026-04-14
Q1 2025
2024-11-30
$0-$34K-$39K$17K$1.3M$41K10-Q 2026-01-14
Q4 2024
2024-08-31
$0-$61K-$48K$26K$2.6M$130K10-K 2025-12-01

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-12022-02-18
Latest annual report10-K2025-12-01
Latest quarterly / interim10-Q2026-06-24
Latest current report8-K2026-10-01

Source: SEC EDGAR submissions feed, 302 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier